Cidara Therapeutics, Inc

About Cidara Therapeutics, Inc

Cidara Therapeutics (“Cidara”) is a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel anti-infectives that have the potential to transform the standard of care and save or improve patients' lives. Our lead product candidate is rezafungin acetate - formerly known as CD101 IV - a novel echinocandin therapy being developed for the treatment and prevention of life-threatening fungal infections. In addition, we have developed a proprietary immunotherapy technology platform, Cloudbreak™, designed specifically to create compounds that directly kill pathogens and also direct a patient's immune cells to attack and eliminate bacterial, fungal or viral pathogens.

Regional Employees
San Diego, CA
We're Hiring!

More about Cidara Therapeutics, Inc